Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300219
- Awardee
-
Pierce Biotechnology Inc. UEI CCSJMTEVB1V7 Part of Thermo Electron Corporation
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,505
Award facts
- Contract value 100% obligated
- $5,504.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockford, IL 61105, USA
Award details come from SAM.gov/FPDS.
About this award
Pierce Biotechnology Inc., a subsidiary of Thermo Electron Corporation, received a $5,504.60 firm fixed price BPA call award from a civilian federal agency on December 19, 2012, with an ultimate completion date of February 28, 2013. The contract, which carries no set-aside designation, pertains to drugs and biologicals and will be performed in Rockford, Illinois. As a call against a blanket purchase agreement, this award represents a task order draw-down from an existing indefinite delivery vehicle, enabling the agency to procure specialized products without initiating a new solicitation.
Thermo Electron Corporation and its subsidiaries have established themselves as leading suppliers of scientific instruments and analytical equipment to federal agencies including the Department of Health and Human Services, Department of Defense, and the Environmental Protection Agency. Pierce Biotechnology's expertise aligns with the parent company's core competencies in providing research and diagnostic instrumentation, with the Financial Services Division of Thermo Electron maintaining significant indefinite delivery contracts, including a $9.5 million blanket purchase agreement with the Food and Drug Administration under the GSA Multiple Award Schedule program. This contract award reflects the ongoing federal procurement relationship for specialized scientific and biological products supporting regulatory, research, and public health initiatives.
Quick answers
Who was awarded contract HHSN26300219?
HHSN26300219 was awarded to Pierce Biotechnology Inc. by Office of the Director (National Institutes of Health) on December 19, 2012.
How much is contract HHSN26300219 worth?
The government has obligated $5,505 on HHSN26300219.
Is contract HHSN26300219 an order under another contract?
Yes. HHSN26300219 is a BPA call under HHSN263199800049380B, a blanket purchase agreement.
Was contract HHSN26300219 competed?
The extent of competition for HHSN26300219 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award